Rights and permissions
About this article
Cite this article
Efaproxiral plus radiotherapy may be beneficial in NSCLC. Inpharma Wkly. 1401, 8 (2003). https://doi.org/10.2165/00128413-200314010-00017
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200314010-00017